News

For cancer survivors like Nathan Calhoun, getting back to normal can sometimes be harder than expected.

A new modeling study provides insight for guideline-writing bodies on who should be screened for anal cancer, how often and with which method.

Spc. Christian Sutton has been on a mission to get soldiers to sign up for the bone marrow registry. He recently got to make a donation himself.

Understanding who is using the latest nicotine product – oral nicotine pouches – is the key to developing future research on the pouches' effects.

Two women found friendship and solidarity as they go about their lives after a glioblastoma diagnosis.

Anthony Cannella has always been willing to try the newest treatments for lymphoma. So he readily agreed to sign up for a CAR-T clinical trial at Hollings.

As home to the state's only neuro-oncologists, MUSC Hollings Cancer Center can offer the latest care options and clinical trials to people with brain tumors.

Dr. Jennifer Dahne's focus on making behavioral health interventions accessible to more people has been recognized with a governor's award.

A simple test to learn about his ancestry uncovered an unexpected syndrome that increases the risk of cancer.

Hollings enrolled the first patient in a clinical trial of a new type of drug, a bifunctional antibody, for head and neck squamous cell carcinoma.